NOT KNOWN DETAILS ABOUT PEMBROLIZUMAB COST

Assessment Pembrolizumab (Keytruda): CADTH Reimbursement Recommendation: Indicator: Together with chemotherapy, for your therapy of Grownup patients with domestically recurrent unresectable or metastatic triple-detrimental breast most cancers which have not acquired prior chemotherapy for metastatic illness and whose tumours express programmed mobi